General Information of This Drug (ID: DMVO2MY)

Drug Name
Solumedrol   DMVO2MY
Synonyms Methylprednisolone succinate; Solumedrol; Methylprednisolone Hemisuccinate [USP]; UNII-5GMR90S4KN; Solu-Medrol; Methylprednisolone hydrogen succinate
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Methylprednisolone + Solumedrol DCBFEXT Methylprednisolone Normal Physiology [2]
------------------------------------------------------------------------------------

References

1 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (MP-C19)
2 ClinicalTrials.gov (NCT02798523) Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids